SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study reveals that older women frequently receive an incorrect breast cancer diagnosis.

2.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

3.

Breast cancer surgery: Study finds overnight hospital stay not important for older patients

4.

Prostate cancer screening program beneficial in top decile of polygenic risk score

5.

DBT Reduced Suicide Attempts in Adolescents with Bipolar Disorder.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot